Joel Prieve

Joel Prieve is a Senior Vice President at Outlook Therapeutics, Inc. where Joel oversees licensing, partnerships, and mergers & acquisitions. Joel has a strong background in business development within the pharmaceutical industry, having previously worked at AmerisourceBergen, Xcenda, and AMAG Pharmaceuticals. Joel's expertise lies in pricing strategies, C-Suite access, key account management, product commercialization, and strategic business planning. Joel holds an MBA in Management and Entrepreneurship from Pepperdine Graziadio Business School.